Trials / Completed
CompletedNCT01991275
Intrathecal Morphine in Robot-assisted Prostatectomy
The Efficacy of Intrathecal Morphine in Patients Undergoing Robot-assisted Prostatectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the efficacy and safety of intrathecal morphine for the patients undergoing robot-assisted prostatectomy
Detailed description
Prostatectomy is the treatment of choice for prostate cancer. The robot-assisted prostatectomy is becoming the most popular surgical method for prostate cancer. The small incision after robot-assisted prostatectomy is thought to reduce the postoperative pain. There is few investigations for the strategy to reduce the postoperative pain of robot-assisted prostatectomy. The intrathecal morphine injection is known to reduce postoperative pain for surgeries like hepatectomy, myomectomy and open prostatectomy. This method, however, is not yet studied for the robot-assisted prostatectomy. This study will investigate the efficacy and safety of intrathecal morphine for the patients undergoing robot-assisted prostatectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | The intravenous patient-controlled analgesia | The intravenous injection of morphine using the patient-controlled analgesia machine |
| DRUG | The intrathecal morphine injection | A single injection of morphine intrathecally |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2013-11-25
- Last updated
- 2015-07-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01991275. Inclusion in this directory is not an endorsement.